Biodegradable Stents Market Driven by Rising Incidences of Coronary and Peripheral Artery Diseases
The global biodegradable stents market features a fairly consolidated landscape with few prominent, multinational companies accounting for a behemoth share in the market. The three leading players—Biotronik, Boston Scientific Corporation, and Abbott Laboratories—account for a combined whopping share of 61.5% of the global market, finds Transparency Market Research (TMR). Relentless focus of these players to consolidate their presence by expanding to new geographic areas have largely enabled them maintain a stronghold in the market.
View full press release